Skip to content
Home/Companies/Biotech/Cyclana Bio

Cyclana Bio

Biotech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Cyclana Bio?

Cyclana Bio is a British Biotech company, currently owned by EKA Ventures since 2025.

Hand-verified · updated 2026-06-30

Open JSON · CC-BY
EKA Ventures
Investor
EKA Ventures
Eka Ventures Fund II · 2026 · Impact

Key facts

HQUK
SectorBiotech
StatusActive

More from Eka Ventures Fund II

Other portfolio companies in the same fund.

Chune
Active
HealthTechUK· 2026
MINML
Minml
Active
ClimateTechUK· 2026
Conveyd
Active
FintechUK· 2025
Ditto Daily
Active
ConsumerUK· 2025
Hesta Health
Hesta Health
Active
HealthTechUK· 2025
Medly AI
Active
EdTechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Cyclana Bio?

Cyclana Bio is currently owned by EKA Ventures, through Eka Ventures Fund II, since 2025.

When did EKA Ventures acquire Cyclana Bio?

EKA Ventures acquired Cyclana Bio in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue